Winship Cancer Institute of Emory University now offers Trans-Arterial Micro-Perfusion (TAMP™) therapy for patients with locally advanced pancreatic cancer, using RenovoRx’s FDA-cleared RenovoCath® device.
TAMP directs chemotherapy to the tumor site while minimizing exposure to healthy tissue. Winship is among approximately 20 cancer centers in the United States offering the treatment.
A Moffitt Cancer Center patient with locally advanced pancreatic cancer is regaining parts of his daily life after a treatment designed to deliver chemotherapy near the tumor.
RenovoRx today announced that it will release third quarter 2026 financial results and business highlights after market close on Thursday, November 5, 2026, and host a conference call and webcast at 4:30 p.m. ET.
A targeted drug-delivery device may help some pancreatic cancer patients get chemotherapy with fewer body-wide side effects.
For 70-year-old Roberta Luna, tending to her garden is therapy — especially trimming rosemary, its purple blooms matching the color she wears every day for pancreatic cancer awareness: purple.